Letter/Communication
Acetaminophen Use in Pregnancy and Neurodevelopmental Outcomes-Reassuring Evidence From a Matched-Sibling Study
JAMA internal medicine
29 Jun 2026
PMID: 42371636
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
In September 2025, the US administration held a press conference stating that its ongoing investigation into the causes of autism had identified maternal use of acetaminophen (paracetamol) during pregnancy as a potential causal factor. This was concerning given that acetaminophen is among the most used medications in pregnancy for the management of pain and fever, in part because alternative options are limited or contraindicated (eg, nonsteroidal anti-inflammatory medications and opioids).
Metrics
2 Record Views
Details
- Title
- Acetaminophen Use in Pregnancy and Neurodevelopmental Outcomes-Reassuring Evidence From a Matched-Sibling Study
- Creators
- Brian K Lee - Drexel UniversityViktor H Ahlqvist - Karolinska Institutet
- Publication Details
- JAMA internal medicine
- Publisher
- JAMA Network
- Number of pages
- 2
- Resource Type
- Letter/Communication
- Language
- English
- Academic Unit
- Epidemiology and Biostatistics; A.J. Drexel Autism Institute
- Web of Science ID
- WOS:001811480300001
- Other Identifier
- 991022194859204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
Source: SDGs in the Output
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Medicine, General & Internal